Levobetaxolol HCl,
LEVOBETAXOLOL HYDROCHLORIDE,
116209-55-3,
Betaxon,
AL 1577A,
UNII-8MR4W4O06J,
Levobetaxolol (hydrochloride),
(S)-Betataxolol hydrochloride,
Levobetaxolol hydrochloride [USAN],
(S)-betaxolol hydrochloride,
8MR4W4O06J,
AL-1577A,
Levobetaxolol hydrochloride (USAN),
CHEBI:59256,
(-)-(S)-1-(p-(2-(Cyclopropylmethoxy)ethyl)phenoxy)-3-(isopropylamino)-2-propanol hydrochloride,
2-Propanol, 1-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)-3-((1-methylethyl)amino)-, hydrochloride, (2S)-,
2-Propanol, 1-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)-3-((1-methylethyl)amino)-, hydrochloride, (S)-,
Betaxon (TN),
AC1L1TNZ,
(2S)-1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(propan-2-ylamino)propan-2-ol hydrochloride,
AC1Q3DQ3,
SCHEMBL42795,
CHEMBL1200837,
HY-B0381B,
AL1577A,
DTXSID20151321,
BCP12964,
s4085,
AKOS030485957,
CS-5154,
(S)-Betaxolol hydrochloride;AL-1577A,
LS-172312,
SW219529-1,
V1820,
D04710,
116209-55-3, 93221-48-8(free base),
UNII-6X97D2XT0O component CHDPSNLJFOQTRK-LMOVPXPDSA-N,
(2s)-1-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)-3-((1-methylethyl)amino)-2-propanol hydrochloride,
(S)-1-(4-(2-(CYCLOPROPYLMETHOXY)ETHYL)PHENOXY)-3-(ISOPROPYLAMINO)PROPAN-2-OL HYDROCHLORIDE,
2-Propanol, 1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-[(1-methylethyl)amino]-, hydrochloride (1:1), (2S)-,
Levobetaxolol,
Betaxolol hydrochloride,
C18H30ClNO3,
C18H29NO3.HCl,
C18-H29-N-O3.Cl-H,
CID60656,
B1778,